FDA Warns That SGLT2 Inhibitors May Result in Ketoacidosis
May 18th 2015The FDA said it had received 20 reports in the 15 months since the first of the SGLT2 inhibitor class was approved, and had continued to receive reports since that time. All drugs in the class were included in the safety communication.
Payers Told to Cover All FDA-Approved Birth Control Methods, Given Guidance on BRCA Testing
May 12th 2015The guidance comes after advocacy groups and members of Congress complained of widespread violations of the Affordable Care Act's requirement that all forms of birth control be covered without a co-payment, not just the low-cost methods. The action also responds to recent reports that payers have balked at requests for BRCA testing even when indicated.
Petition for Less Meat, School Lunch Hearing Come in Days Before Dietary Guidelines Deadline
May 11th 2015February's report from the Dietary Guidelines Advisory Committee called for an emphasis on plant-based diets and less red or processed meat. Protests from the meat industry followed, and the comment period was extended until Friday.
No Progress in Florida Hospital Aid Talks, as Deadline Looms
May 7th 2015Health and Human Services Secretary Sylvia Mathews Burwell yesterday rejected Governor Rick Scott's proposal to extend the current funding mechanism, which this year brought $1.3 billion in federal funds to hospitals that care for high numbers of uninsured patients.
A Look at the Unhealthiness of Sitting, and a Call for More Research on Its Effects
May 5th 2015The meta-analysis in Annals of Internal Medicine found that small doses of exercise were not enough to offset the effects of long periods of sitting on all-cause mortality and chronic disease, including diabetes.
Implementing JNC 8 Guidelines Is Generally Cost-Effective, According to NEJM Findings
May 5th 2015The argument for cost-effectiveness has become important in the care of patients with diabetes and other comorbidities, as patients typically take multiple medications, each with its own cost-both to the payer and to the patient in the form of a co-pay-as well as some side effects.
Medicaid Expansion Brings Almost 12 Million Into Ranks of Insured, CMS Reports
May 5th 2015The number of Americans finding coverage through Medicaid expansion equals those who signed up for private insurance on the exchanges, according to new data. Montana has just passed legislation to become the 29th state to expand Medicaid.
US Individual Insurance Market Grows 46% in First Year Under ACA, Study Finds
May 1st 2015In 2014, low- and moderate-income consumers were able to use premium subsidies to buy health coverage on Marketplaces under the Affordable Care Act. The individual health insurance market had been relatively flat for 3 years' prior.
ADA, AMA, and YMCA Praise Introduction of Medicare Diabetes Prevention Act
April 30th 2015Today's call for Medicare to cover the Diabetes Prevention Program is part of a broader effort by advocacy groups and the AMA to identify those with prediabetes and intervene before people develop full-blown diabetes.
Ohio Legislators May Take Control of Medicaid Expansion from Governor
April 29th 2015House Republicans say that Medicaid takes up too much of the state's budget for them not to have more say in who receives it. They also included budget language calling for Medicaid officials to ask CMS to allow healthcare savings accounts for almost all beneficiaries.
When Moving to Collaborative Care, a Challenge Is Figuring Out How to Pay for It
April 29th 2015Studies have shown that embedding behavioral health services into the primary care practice produces better health outcomes for patients with diabetes, while reducing indications of depression. The challenge is figuring out how to make the transition to new payment models that reward such care.
Review Touts Benefits of New Cholesterol Drugs, but Editorial Calls for Cautious Enthusiasm
April 28th 2015A review of 24 trials covering more than 10,000 patients confirmed earlier findings that PCSK9 inhibitors dramatically reduce cholesterol and risk of heart attacks. But an editorial that appeared alongside the meta-analysis in Annals of Internal Medicine said long-term studies are needed on this new drug class.